The adenosine-mediated immunosuppressive pathway plays a pivotal role in modulating immune responses within the tumor microenvironment, particularly through the enzymatic activity of CD39, which catalyzes the conversion of extracellular ATP to adenosine. The gene discussed is ENTPD1; the disease is neoplasm.